Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.84 USD
-0.06 (-1.54%)
Updated Aug 2, 2024 12:39 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Brokerage Reports
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 81 - 100 ( 145 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis Industry: Monthly Performance and Valuations February ''23
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis State of the Union: A Year of Resiliency With Focus on 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: 280E Removal Would Bring More Than Just Financial Leverage
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly Rehash: U.S. Interstate Commerce the Long Game
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Industry Preserving Cash in Prep for a Nuclear Winter
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Scoring the MSOs with Cash Flow, Debt and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
2023 Outlook: Optimistic Well-Capitalized Businesses with a Clear Path to Positive FCF Should Find Their Footing
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Quality at a Discount: FCF Yield Exceeds 15% by H223
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Putting 2022 Performance & Valuations Behind Us
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis Update: NY Regulations a Different Framework, Verticality Challenged
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: 3Q Cannabis Earnings Recap, Inflationary Pressures Impacting NT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Q322 Beat: Riding High on New Jersey as Margin Expansion Drives EBITDA Outperformance, Capex Slowdown Supports FCF Growth
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Q3 Fundamentals Appear Soft but Legislative Reform Looks Promising
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis Industry Update: 3Q22 Earnings - Week I Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department